Bridgeway Capital Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.4K | Hold |
34,000
| – | – | ﹤0.01% | 1142 |
|
|
2025
Q1 | $31.5K | Hold |
34,000
| – | – | ﹤0.01% | 1141 |
|
|
2024
Q4 | $29.2K | Hold |
34,000
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q3 | $56.4K | Hold |
34,000
| – | – | ﹤0.01% | 1204 |
|
|
2024
Q2 | $54.7K | Sell |
34,000
-5,100
| -13% | -$8.21K | ﹤0.01% | 1207 |
|
|
2024
Q1 | $89.5K | Sell |
39,100
-2,900
| -7% | -$6.64K | ﹤0.01% | 1218 |
|
|
2023
Q4 | $94.5K | Hold |
42,000
| – | – | ﹤0.01% | 1250 |
|
|
2023
Q3 | $127K | Hold |
42,000
| – | – | ﹤0.01% | 1179 |
|
|
2023
Q2 | $173K | Hold |
42,000
| – | – | ﹤0.01% | 1168 |
|
|
2023
Q1 | $158K | Hold |
42,000
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q4 | $235K | Buy |
42,000
+27,000
| +180% | +$151K | 0.01% | 1051 |
|
|
2022
Q3 | $100K | Buy |
+15,000
| New | +$100K | ﹤0.01% | 1267 |
|
|
2021
Q1 | – | Sell |
-5,510
| Closed | -$333K | – | 1413 |
|
|
2020
Q4 | $333K | Hold |
5,510
| – | – | 0.01% | 1089 |
|
|
2020
Q3 | $435K | Sell |
5,510
-954
| -15% | -$75.3K | 0.01% | 950 |
|
|
2020
Q2 | $404K | Buy |
6,464
+1,534
| +31% | +$95.9K | 0.01% | 929 |
|
|
2020
Q1 | $261K | Sell |
4,930
-1,168
| -19% | -$61.8K | 0.01% | 973 |
|
|
2019
Q4 | $738K | Buy |
6,098
+2,058
| +51% | +$249K | 0.01% | 817 |
|
|
2019
Q3 | $733K | Buy |
+4,040
| New | +$733K | 0.01% | 817 |
|